8W9A image
Entry Detail
PDB ID:
8W9A
EMDB ID:
Keywords:
Title:
CryoEM structure of human PI3K-alpha (P85/P110-H1047R) with QR-7909 binding at an allosteric site
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-09-05
Release Date:
2024-04-17
Method Details:
Experimental Method:
Resolution:
2.70 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Chain IDs:A
Chain Length:1068
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Phosphatidylinositol 3-kinase regulatory subunit alpha
Chain IDs:B
Chain Length:724
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Cryo-EM structures reveal two allosteric inhibition modes of PI3K alpha H1047R involving a re-shaping of the activation loop.
Structure 32 907 917.e7 (2024)
PMID: 38582077 DOI: 10.1016/j.str.2024.03.007

Abstact

PI3Kα is a lipid kinase that phosphorylates PIP2 and generates PIP3. The hyperactive PI3Kα mutation, H1047R, accounts for about 14% of breast cancer, making it a highly attractive target for drug discovery. Here, we report the cryo-EM structures of PI3KαH1047R bound to two different allosteric inhibitors QR-7909 and QR-8557 at a global resolution of 2.7 Å and 3.0 Å, respectively. The structures reveal two distinct binding pockets on the opposite sides of the activation loop. Structural and MD simulation analyses show that the allosteric binding of QR-7909 and QR-8557 inhibit PI3KαH1047R hyper-activity by reducing the fluctuation and mobility of the activation loop. Our work provides a strong rational basis for a further optimization and development of highly selective drug candidates to treat PI3KαH1047R-driven cancers.

Legend

Protein

Chemical

Disease

Primary Citation of related structures